Company Overview and News

 
New Mexico and Texas See a Rise in Onshore Drilling Rigs

2018-05-21 zacks
In its weekly release, Baker Hughes (BHGE - Free Report) , a GE company, reported an increase in rig count in the United States.

1
DO / Diamond Offshore Drilling, Inc. 8-K (Current Report)

2018-05-17 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

 
Trading Volatile Oil Services Stocks Is Challenging Even As Crude Oil Futures Set New Multiyear Highs

2018-05-14 seekingalpha
Nymex crude oil futures have been above their technical ‘reversion to the mean’ since 2018 began.

 
Oil Gets Further Lift from EIA Data, Consolidates Above $70

2018-05-10 zacks
The U.S. Energy Department's weekly inventory release showed that crude stockpiles recorded a fall of 2.2 million barrels, the first increase in three weeks, and significantly larger than expected. On a further bullish note, the report revealed that refined product inventories, gasoline and distillate, both dropped from their week earlier levels. Importantly, the positive data sets have added to the strong sentiment in the oil market.

1
DO / Diamond Offshore Drilling, Inc. 8-K (Current Report)

2018-05-08 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

1
Ensco: Not Yet

2018-05-08 seekingalpha
Ensco is being held back by the Atwood Oceanics deal that added modern deepwater rigs without work.

 
Diamond Offshore (DO) Incurs Loss in Q1, Revenues In Line

2018-05-01 zacks
Diamond Offshore Drilling Inc. (DO - Free Report) incurred an adjusted loss of 16 cents per share in first-quarter 2018, narrower than the Zacks Consensus Estimate of a loss of 20 cents. The company reported adjusted earnings of 17 cents per share in the year-ago quarter.

 
Diamond Offshore Drilling's (DO) CEO Marc Edwards on Q1 2018 Results - Earnings Call Transcript

2018-04-30 seekingalpha
Diamond Offshore Drilling Inc. (NYSE:DO) Q1 2018 Earnings Conference Call April 30, 2018 8:30 AM ET

 
Diamond Offshore Posts Smaller-Than-Expected Quarterly Loss

2018-04-30 rigzone
April 30 (Reuters) - Diamond Offshore Drilling Inc reported a smaller-than-expected quarterly loss on Monday, helped by new contracts for the company's deep-water rigs.

 
DO / Diamond Offshore Drilling, Inc. 10-Q (Quarterly Report)

2018-04-30 sec.gov
10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION

 
DO / Diamond Offshore Drilling, Inc. 8-K (Current Report)

2018-04-30 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

 
Ensco Q1 Conference Call Takeaways

2018-04-29 seekingalpha
Shallow-water market is seeing increased demand due to strength in the North Sea and the Middle East.

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

20h - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

20h - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

CUSIP: 25271C102